Search Results 1041-1050 of 18374 for Immunode

1. A Study of Using Mesenchymal Stem Cells Developed from the Patients Own Fat Tissue for Reducing Hemodialysis Arteriovenous Fistula Failure - Mayo Clinic

   Immunodeficiency including AIDS / HIV or Active autoimmune disease. Documented hypercoagulable state or history of 2 or more DVTs or other spontaneous ...

2. Ixazomib Citrate, Pomalidomide, Dexamethasone, and Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Negative human immunodeficiency virus (HIV), hepatitis B and C test. Willing to follow the requirements of the Pomalyst REMS program. Willing to return to ...

3. A Study to Assess the Effectiveness, Safety, and Tolerability of Brensocatib in Participants with Non-Cystic Fibrosis Bronchiectasis (ASPEN) - Mayo Clinic

   Current smokers as defined per Centers for Disease Control (CDC). 4. Known or suspected immunodeficiency disorder, including history of invasive

4. Publications - Olayemi Sokumbi, M.D. - Mayo Clinic

   Exfoliative cheilitis related to psychologic factors uncovered during primary immunodeficiency evaluation. Dermatol Online J. 2021 Jun 15; 27 (6) Epub 2021 ...

5. MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer - Mayo Clinic

   Human immunodeficiency virus (HIV)-positive test result or history of other immunodeficiency. History of organ transplantation. History of chronic hepatitis ...

6. Evaluation Of The AMICUS Extracorporeal Photopheresis (ECP) System In Patients With Chronic Graft Versus Host Disease - Mayo Clinic

   Subjects who have a known human immunodeficiency virus (HIV) or hepatitis B or C virus infection. Subjects who have a known hypersensitivity or allergy to ...

7. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

   Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive; Hypersensitivity to pegfilgrastim or Escherichia (E.) coli ...

8. A Study Comparing Tarlatamab, Durvalumab, Carboplatin, And Etoposide Versus Durvalumab, Carboplatin, And Etoposide In First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) - Mayo Clinic

   * Presence of active human immunodeficiency virus (HIV) or active Hepatitis (B/C) infection. * Evidence or interstitial lung disease (ILD) or active, non ...

9. Publications - Rohit D. Divekar - Mayo Clinic

   Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2017 May; 118 (5):614-620 ...

10. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Are infected with human immunodeficiency virus (HIV);; QuantiFERON®-TB test or Purified Protein Derivative (PPD) skin test, or both, according to local ...